Literature DB >> 9169765

Distinct mechanisms of immunosuppression as a consequence of major surgery.

T Hensler1, H Hecker, K Heeg, C D Heidecke, H Bartels, W Barthlen, H Wagner, J R Siewert, B Holzmann.   

Abstract

Altered host defense mechanisms after major surgery or trauma are considered important for the development of infectious complications and sepsis. In the present study, we demonstrate that major surgery results in a severe defect of T-lymphocyte proliferation and cytokine secretion in response to coligation of the antigen receptor complex and CD28. During the early postoperative course, reduced cytokine secretion was observed for interleukin-2 (IL-2), gamma interferon, and tumor necrosis factor alpha, which are associated with the Th1 phenotype of helper T lymphocytes, and for IL-4, the index cytokine of Th2 cells. During the late postoperative course, T-cell cytokine secretion increased to normal levels. Production of the anti-inflammatory cytokine IL-10 was altered, with different kinetics being selectively elevated during the late postoperative course. In contrast, the capacity of peripheral blood monocytes to present bacterial superantigens and to stimulate T-cell proliferation was normal or enhanced after surgery despite a significant loss of cell surface HLA-DR molecules. Thus, the level of major histocompatibility complex class II protein expression does not appear to predict the antigen-presenting capacity of monocytes obtained from surgical patients with uneventful postoperative recovery. Secretion of IL-1beta and IL-10 by endotoxin-stimulated peripheral blood monocytes was increased at different time points after surgery. Major surgery therefore results in a distinct pattern of immune defects with a predominant defect in the T-cell response to T-cell receptor- and CD28 coreceptor-mediated signals rather than an impaired monocyte antigen-presenting capacity. Suppression of T-cell effector functions during the early phase of the postoperative course may define a state of impaired defense against pathogens and increased susceptibility to infection and septic complications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169765      PMCID: PMC175317          DOI: 10.1128/iai.65.6.2283-2291.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.

Authors:  C V Harding; E R Unanue
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

Authors:  C B Thompson
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

4.  Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient.

Authors:  M J Hershman; W G Cheadle; S R Wellhausen; P F Davidson; H C Polk
Journal:  Br J Surg       Date:  1990-02       Impact factor: 6.939

5.  A theory of self-nonself discrimination.

Authors:  P Bretscher; M Cohn
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

6.  Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation.

Authors:  E Faist; T S Kupper; C C Baker; I H Chaudry; J Dwyer; A E Baue
Journal:  Arch Surg       Date:  1986-09

7.  Depressed interferon gamma production and monocyte HLA-DR expression after severe injury.

Authors:  D H Livingston; S H Appel; S R Wellhausen; G Sonnenfeld; H C Polk
Journal:  Arch Surg       Date:  1988-11

8.  Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma.

Authors:  E Faist; A Mewes; C C Baker; T Strasser; S S Alkan; P Rieber; G Heberer
Journal:  J Trauma       Date:  1987-08

9.  Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns.

Authors:  J J Wood; M L Rodrick; J B O'Mahony; S B Palder; I Saporoschetz; P D'Eon; J A Mannick
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

10.  Alteration of monocyte function following major injury.

Authors:  E Faist; A Mewes; T Strasser; A Walz; S Alkan; C Baker; W Ertel; G Heberer
Journal:  Arch Surg       Date:  1988-03
View more
  83 in total

1.  Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzees.

Authors:  F N Lauw; A A te Velde; P E Dekkers; P Speelman; J M Aerts; C E Hack; S J van Deventer; T van der Poll
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  The percentage of CD31+ T cells decreases after open but not laparoscopic surgery.

Authors:  I Kirman; V Cekic; N Poltaratskaia; Z Asi; S Conte; D Feingold; K A Forde; E H Huang; R L Whelan
Journal:  Surg Endosc       Date:  2003-03-07       Impact factor: 4.584

3.  Changes in T-lymphocytes' viability after laparoscopic versus open cholecystectomy.

Authors:  Ilias P Gomatos; Leonidas Alevizos; Olga Kalathaki; Harilaos Kantsos; Agapi Kataki; Emmanuel Leandros; George Zografos; Manousos Konstantoulakis
Journal:  Int Surg       Date:  2015-04

4.  TNF-alpha is a mediator of the anti-inflammatory response in a human neonatal model of the non-septic shock syndrome.

Authors:  S Hassett; P Moynagh; D Reen
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

Review 5.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

6.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

Review 7.  Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.

Authors:  Amedeo Amedei; Elena Niccolai; Domenico Prisco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 8.  The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.

Authors:  Nicholas S Ward; Brian Casserly; Alfred Ayala
Journal:  Clin Chest Med       Date:  2008-12       Impact factor: 2.878

9.  Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection.

Authors:  A Belizon; E Balik; P Horst; D Feingold; T Arnell; T Azarani; V Cekic; R Skitt; S Kumara; R L Whelan
Journal:  Surg Endosc       Date:  2008-01-18       Impact factor: 4.584

10.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.